EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 343 filers reported holding EXELIXIS INC in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $481,290 | +37.5% | 22,027 | +20.3% | 0.00% | +100.0% |
Q2 2023 | $350,019 | -37.8% | 18,316 | -36.9% | 0.00% | -50.0% |
Q1 2023 | $563,104 | -30.7% | 29,011 | -42.7% | 0.00% | -50.0% |
Q4 2022 | $812,378 | +150.7% | 50,647 | +145.0% | 0.00% | +100.0% |
Q3 2022 | $324,000 | -24.7% | 20,669 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $430,000 | -8.3% | 20,669 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $469,000 | -17.7% | 20,669 | -27.2% | 0.00% | -33.3% |
Q4 2020 | $570,000 | +12.0% | 28,377 | +36.3% | 0.00% | 0.0% |
Q3 2020 | $509,000 | -22.6% | 20,820 | -24.9% | 0.00% | -25.0% |
Q2 2020 | $658,000 | +6.0% | 27,728 | -23.2% | 0.00% | -20.0% |
Q1 2020 | $621,000 | +96.5% | 36,084 | +143.8% | 0.01% | +150.0% |
Q2 2019 | $316,000 | -12.7% | 14,803 | -2.7% | 0.00% | 0.0% |
Q1 2019 | $362,000 | – | 15,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |